Lymphocytic Leukemia, Acute Clinical Trials

A listing of Lymphocytic Leukemia, Acute medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

La Jolla California 92093

A clinical trial seeking patients for a research study for the treatment of Acute Lymphocytic Leukemia or Adult Lymphoblastic Lymphoma

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Acute Lymphocytic Leukemia or Adult Lymphoblastic Lymphoma

Sacramento California 95817

A clinical trial seeking patients for a research study for the treatment of Acute Lymphocytic Leukemia or Adult Lymphoblastic Lymphoma

San Francisco California 94143

A clinical research study of DS-3032b for the treatment of Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

San Francisco California 94143-0324

A clinical trial seeking patients for a research study for the treatment of Acute Lymphocytic Leukemia or Adult Lymphoblastic Lymphoma

New York

Bronx New York 10467

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

Buffalo New York 14263

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

Texas

Houston Texas 77031

A clinical research study of DS-3032b for the treatment of Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Houston Texas 77030

A clinical trial seeking patients for a research study for the treatment of B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia or Non-hodgkin Lymphoma

Houston Texas 77030

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

China

Suzhou Jiangsu 215123

A clinical trial seeking patients for a research study of anti-CD19 CAR-NK cells

Suzhou Jiangsu 215123

A Phase 1/Phase 2 clinical study for patients using PCAR-019 (anti-CD19 CAR-T cells)

Suzhou Jiangsu 215123

Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma